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The  discovery  that  a-bungarotoxin (ct-BTX),  a 
polypeptide isolated from the venom of Bungarus 
multicinctus, binds specifically and irreversibly to 
the  nicotinic acetylcholine  receptor  (AChR)  (3) 
has provided a tool for the study of the localization 
and turnover of the receptor in vertebrate muscle. 
Previous  studies  by  Berg  and  Hall  (1,  2)  have 
suggested that the recovery after a-BTX binding at 
adult  neuromuscular junctions is  relatively slow 
compared to that of the postdenervation extrajunc- 
tional  receptor.  However,  no  physiological data 
nor precise time scale for the recovery of  junctional 
receptors  was  given.  ~  In  the  present  study  we 
approached the question of recovery of junctional 
AChR  after  a-BTX  by  investigating the  in vivo 
recovery of nerve-stimulated muscle contraction in 
mouse sternomastoid muscle, after inactivating  the 
response with a-BTX. 
In  Vivo Neuromuscular Preparation 
The right sternomastoid muscle was exposed in 
anesthetized mice,  and  a  loop of the  innervating 
nerve (branch of the spinal accessory) was drawn 
1  After this paper was submitted for publication, a study 
by  Chang  and  Huang  (1975. Nature [Lond.]. 
253:643-644) did in fact give a time scale for recovery of 
inactivated junctional receptor. This study is similar to 
that of Berg and Hall (i) in that it bases its criterion of 
recovery on  the  removal of  [~251]a-BTX radioactivity 
from a diaphragm preparation and comes to conclusions 
similar to those of Berg and Hall. 
into  a  suction electrode.  The  muscle could  thus 
be stimulated indirectly (neurally) without cutting 
the  nerve.  It  could  also  be  stimulated  directly 
(field  stimulation) by  a  pair  of  blunted  needle 
electrodes  in  contact  with  the  muscle.  Muscle 
concentration was monitored by a polished needle 
inserted  into  the  muscle  and  attached  to  an 
isotonic  transducer  (Harvard  Apparatus  Co., 
Inc.,  Millis,  Mass.).  In  this  preparation,  maxi- 
mum  tetanic  contraction  amplitudes  were  pro- 
duced  at  stimulation  frequencies  above  70  Hz. 
We  found  that  normally  the  maximum  tetanic 
contraction obtainable from  the  muscle was  the 
same  for  both  the  direct  and the  indirect modes 
of stimulation, provided the voltage necessary to 
produce  this  maximal  tetanic  contraction  was 
determined each  time for each  mode of stimula- 
tion. Furthermore, the absolute amplitude of the 
recorded  muscle  contraction  depended  on  the 
location  of  the  transducer  needle.  However, 
since  we  recorded  the  muscle  contractions pro- 
duced by both modes of stimulation by the same 
transducer needle, we had, at each recording ses- 
sion, an internal standard of muscle contraction, 
i.e.  the  field-stimulated response,  against  which 
to compare the neurally evoked response. 
Recovery of Neuromuscular Response 
after ol-BTX 
The  maximum  tetanic  contraction  of  the  ex- 
posed muscle was first established by stimulating 
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tings. Tetanic contraction was used in order to ob- 
tain  maximal  recruitment  of  available  fibers. 
(The  tetanic  contraction  amplitude  was  roughly 
four  times  that  obtained  by  single  twitch  stimu- 
lations.)  To  inactivate  the  AChR,  the  muscle 
was  then  bathed  in  a-BTX  (10 -6  M  in  Krebs- 
Ringer  solution)  while  the  nerve  was  stimulated 
every  15  min  with  short  (~2  s)  trains  of pulses 
(80  100  Hz)  until  no  tetanic muscle contractions 
could  be  recorded  (Fig.  I).  Inactivation  took  a 
total of ~  1-2 h (about twice as long as to eliminate 
single  twitch  responses). 2  The  a-BTX  did  not 
affect  the  muscle  response  to  direct  stimulation. 
The  incision  was  then  closed,  and  the  animals 
were  allowed  to  survive  (survival  rate  was 
~50  60%).  At  varying  daily  intervals,  animals 
were  reanesthetized,  and  the  amplitude  of maxi- 
mal  tetanic  muscular  response  to  both  modes  of 
stimulation was checked.  Recovery was  tested  on 
a  total  of  10  animals.  No  animal  was  tested  on 
more  than  two  different  days  to  minimize  af- 
fecting the results by muscle damage. 
Percent  recovery  was  determined  (Fig.  2)  by 
comparing  the  maximum  tetanic  contraction  ob- 
tainable by nerve stimulation with that obtainable 
by direct  muscle stimulation, e.g.,  normal muscle 
always  gives  100%.  Although  there  was  con- 
siderable  variability  from  animal  to  animal,  re- 
covery  of  neuromuscular  contraction  occurred 
in  4-8  days  (half  time  of  ~3  days),  i.e.,  of  4 
animals  tested  between  4  8  days  after  inactiva- 
tion,  all  recovered to  better than 90%  within that 
time. 
Our  finding of relatively little recovery in  1 day 
is consistent with the report of Berg and  Hall (2). 
However,  if one can equate absence of removal of 
radioactivity  with  absence  of  physiological  re- 
covery,  the  fact  that  recovery  occurs  within  4-8 
days  in  our  system  seems  to  be'at  variance  with 
an  earlier  report  by  the  same  authors  (I)  that 
66%  of the  radioactivity  remains at the end  plate 
regions  5  days  after  [12~I]a-BTX  (see  also  foot- 
note  1).  The  different  experimental  procedures 
2 We have found (see footnote 3) that, after this inactiva- 
tion endpoint,  more than 90%  of the available a-BTX 
binding sites are occupied, i.e.,  if after inactivation with 
nonradioactive  a-BTX  the  muscle  is  incubated  with 
[~251]a-BTX  for  an  additional  2  h,  the  amount  of 
radioactivity bound  to  the end  plate  (assessed  by  EM 
autoradiography) is less than 10% of that which is bound 
when  the  initial  inactivation  is  done  by  radioactive 
a-BTX  and  is  localized  in essentially the same place. 
INDIRECT  DIRECT 
FIGURE  I  Stimulation mode. Tetanus 0 min (curve I), 
60  min  (curve  2),  102  min  (curve  3),  and  145  rain 
(curve  4)  after  a-BTX.  Amplitude  of  tetanic  muscle 
response to indrect (nerve) and direct (field) stimulation 
in  the  presence  of  a-BTX.  Normally  (curve  1)  the 
maximum  muscle  contraction  is  the  same  for  both 
modes  of stimulation.  After  145 rain in a-BTX  (curve 
4)  the  response  to  indirect  (nerve)  stimulation  is  not 
above background,  whereas the  response to  the direct 
stimulation  is  unchanged  (arrows  represent  end  of 
stimulation period). 
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FIGURE 2  Percent recovery of the neuromuscular re- 
sponse. ([Amplitude  of  neurally  evoked  contraction]/ 
[amplitude  of  field  stimulation  contraction])  ￿  100%. 
Three animals (A, NI,  and |  ) were each tested on two 
different occasions to show individual variations in speed 
of recovery. All other animals (￿  were tested only once. 
The solid line represents the average recovery curve, but, 
due to the individual animal variations, is not intended to 
represent a universal recovery function. 
may  account  for  the  difference  in  results.  We 
looked  at  recovery  of  a  physiological  response, 
while  they  looked  at  removal  of radioactivity.  A 
possibility remains that  some  of the  radioactivity 
seen  by  Berg  and  Hall  is  due  to  migration  and 
internalization  of  the  a-BTX  (or  an  a-BTX  re- 
ceptor  complex)  which  then  remained  in  the  tis- 
sue for prolonged periods. 
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Various studies with actinomycin D or inhibitors 
of  protein  synthesis  (2,  4,  6)  have  led  to  the 
conclusion that the production and turnover of the 
extrajunctional AChR  involves an  active  meta- 
bolic process. 
To see whether this is also true for the junctional 
receptors, we looked at the effect of actinomycin D 
on  the  recovery of function after  a-BTX  in the 
sternomastoid preparation.  (We  did  not  use  cy- 
cloheximide or other inhibitors of protein synthe- 
sis,  as  they  are  too  toxic  for  long-term  in  vivo 
studies.) Grampp et al. (6) have shown that, from 
12  h  to  31/2  days  after  a  single  injection  of 
actinomycin D,  the  incorporation of [3H]uridine 
into  RNA  of mouse  muscle homogenates is  re- 
duced by 50%. 
In our study, two groups of animals (four mice 
each) were treated  as  follows:  Group  1 had  their 
neuromuscular contractions  inactivated  with  a- 
BTX as described above. After these animals had 
recovered  from  the  anesthesia,  they  received  an 
intraperitoneal  injection  of  actinomycin  D  (0.5 
mg/kg weight). Group 2 received  a  similar injec- 
tion of actinomycin D  after a  sham operation in 
which no a-BTX was  administered. The animals 
were weighed  at daily intervals, and 3  4 days later 
they were  anesthetized, and their muscle response 
was determined as described above. 
The dose of actinomycin used was not lethal to 
any of the  animals, but considerable weight  loss 
(~5 g in 3-4 days) was seen in both groups. When 
neuromuscular response was tested 3  4 days after 
the actinomycin D injection, we found that, in the 
animals without  a-BTX,  actinomycin D  did  not 
affect  the  response  to  indirect  stimulation  (at 
80  100  Hz),  whereas  in  the  animals pretreated 
with a-BTX, actinomycin D prevented the normal 
recovery  of  neurally evoked  muscle contraction. 
By  4  days,  recovery  was  less  than  10%. These 
results suggest that the in vivo recovery seen after 
inactivation of the junctional receptor with a-BTX 
is  an  active  metabolic  process  involving RNA 
synthesis,  a  finding  similar  to  that  previously 
reported for the extrajunctional receptor. 
Fambrough (4) had reported that ACh sensitiv- 
ity at diaphragm neuromuscular  junctions is unaf- 
fected by actinomycin D for 3 days in vitro and on 
that basis suggested that in that time scale there is 
essentially no turnover of junctional AChR. To be 
consistent with  this interpretation given by Fam- 
brough,  one  could  conclude  that  at  the  adult 
neuromuscular junction there is normally little or 
no  turnover of  AChR  and  that  inactivation by 
a-BTX triggers de novo synthesis of receptor and 
degradation of the  complexed receptor or other- 
wise triggers an active process necessary to reacti- 
vate the  receptor.  Some caution is  required with 
such  an  interpretation  both  of  our  own  and 
Fambrough's  data,  however,  since  there  is  evi- 
dence that actinomycin D may also inhibit normal 
degradation  and  release  of cellular material and 
that synthesis and degradation may be linked (7, 
9  11). The fact that actinomycin D does not affect 
neurally-evoked  muscle  contraction  in  non-a- 
BTX-treated animals may then reflect an interfer- 
ence  with  normally occurring degradation of re- 
ceptor. The data are thus also compatible with an 
interpretation that normally there occurs a.steady 
state  of junctional AChR  turnover which  is  re- 
vealed  both  by the  post-a-BTX  recovery and its 
interference  by  actinomycin  D.  At  present  we 
cannot distinguish between these alternatives. 
Fine Structure and EM A utoradiography 
Preparations examined by electron microscopy 
immediately after a-BTX inactivation and at vari- 
ous times during recovery showed  essentially nor- 
mal muscle and end plate morphology. 
In a  previous study (5),  we found that  [125I]a- 
BTX  bound  only  to  a  zone  at  the  top  of  the 
junctional folds and was not uniformly distributed 
throughout the folds. Subsequently, we determined 
that  this  constitutes a  density of roughly 30,000 
sites per ~tm  2 of postsynaptic membrane within this 
zone.  3 This raises questions regarding the role of 
the depths of the junctional folds.  The possibility 
that membrane flow may be involved either during 
the  formation  of  new  receptors  or  during  the 
removal  of  the  BTX-receptor  complex  was  ex- 
plored  by  preliminary  studies  during  recovery; 
EM  autoradiography was  used  by the  procedure 
of  Salpeter  and  Bachmann  (8).  First,  to  deter- 
mine whether during recovery one can detect new 
sites at positions other than their normal location, 
we  inactivated neurally evoked  contraction with 
non-radioactive a-BTX  in  one  animal and then, 
2  days  later,  used  [~2~I]a-BTX  to  inactivate the 
newly  recovered  response  (which  was  ~40%  of 
normal). We found that the localization of radio- 
activity  was  restricted  to  the  tops  of  the junc- 
tional folds, and, thus, was similar to that seen in 
the  normal animals. Secondly, to  study possible 
movement  of  bound  radioactivity  during  re- 
3 Fertuck,  H.  C.,  and  M.  M.  Salpeter. Manuscript in 
preparation. 
BRIEF NOTES  211 covery,  we  partially  inactivated  neuromuscular 
response  by  [I~I]a-BTX  in  three  animals,  killed 
the  animals  at  2,  4,  or  8  days  later,  and  again 
prepared  their end  plates  for examination  by  EM 
autoradiography.  We  found  that  some  labeling 
(~20-25%  of that  seen  immediately after full in- 
activation  of  the  muscle  response  by  [125I]a- 
BTX) was still evident at the neuromuscular junc- 
tion  even 8 days after incubation  with radioactive 
toxin,  at  which  time muscle contraction  was fully 
recovered.  The  localization  of the  residual  label 
was  again  primarily  in  a  zone  at  the  top  of the 
junctional  folds  (Fig.  3).  (No  information  is  at 
present  available  regarding  the  nature  of  this 
residual  radioactivity.)  We,  however,  saw  no 
evidence  of  mass  internalization  of  radioactivity 
down  the  folds,  into  the  muscle,  or  into  any 
extrajunctional  region.  EM  autoradiography  is 
capable of localizing only the radioactivity which is 
retained  during  fixation  and  other tissue  process- 
ing.  We can, therefore,  not exclude the possibility 
that  internalization  of radioactivity  in  some solu- 
ble  form  is  in  fact  part  of the  normal  recovery 
process.  There is, however, no indication,  in these 
preliminary  studies,  of  internalization  or  mem- 
brane  flow of bound  radioactivity. 
CONCLUSION 
Our  method  of measuring  recovery  involved the 
overall  response  of the  muscle  in  vivo.  Since  we 
wanted  to study the response in vivo and therefore 
could  not  measure  isometric  contraction  in  abso- 
lute terms, we devised a measure of recovery which 
was  based  on  a  comparison  between  the contrac- 
tion capacity of the muscle when stimulated by the 
nerve  and  that  when  stimulated  directly.  This 
provided a valid quantitative measure of recovery if 
recorded  with the same recording needle, since the 
two responses are normally identical, and since the 
direct  stimulation  response  was  unaffected  by 
a-BTX. Our measure did not allow us to draw any 
conclusions, however,  regarding the rate of recov- 
ery at the individual end plates. The question is left 
open as to whether the gradual recovery of overall 
muscle  function  represents  a  variable  rate  of 
recovery of receptor  at  the different junctions,  or 
whether  the  rate  of recovery  of ACh  receptor  is 
identical  at  all  the  junctions,  yet  different  end 
plates  have  different  threshold  conditions  for  re- 
sponse. 
We can conclude, however, that full recovery of 
neurally evoked contraction  after a-BTX inactiva- 
tion occurs in vivo over a 4-8-day period (halftime 
~3  days)  and  that  it  seems  to  be  an  active 
metabolic  process  involving RNA  synthesis.  This 
in  vivo  functional  recovery  is  slower  than  that 
reported  for the turnover of extrajunctional  recep- 
tors  after  denervation,  but  is  faster  than  that 
reported  for  the  removal  of  end  plate-bound 
radioactivity  from  diaphragm  preparations.  The 
quantitative relationship between functional recov- 
ery  and  removal  of  radioactivity  remains  to  be 
resolved. 
SUMMARY 
Acetylcholine receptors were inactivated in vivo at 
the  mouse  neuromuscular  junction  using  a-bun- 
garotoxin  (a-BTX),  It  was  found  that  neurally 
FIGURE  3  EM  autoradiogram  showing  [IzsI]a-BTX  label  8  days  after  binding  at  the neuromuscular 
junction of mouse sternomastoid  muscle.  The residual  label is not distributed  over the full depth of the 
junctional folds (jJ) but  is primarily concentrated in a zone at the top of the folds adjacent to the axon (a), 
and  thus similar to that seen immediately after incubation with  [~251]a-BTX (5).  ￿  21,500. 
212  BglEr  NOTES produced  muscle contraction recovered within 4  8 
days  (halftime  ~3  days).  Actinomycin  D  inter- 
fered  with this recovery,  but did not affect normal 
nerve-stimulated  muscle  contraction.  If  the  re- 
sponse was initially eliminated by [~2~I]a-BTX and 
the end plates examined by EM  autoradiography, 
no  evidence  of  mass  internalization  of  bound 
radioactivity  during  recovery  was  seen.  The  fine 
structure  of  the  end  plates  and  muscle  was  un- 
altered  during  the  post-a-BTX  recovery  period. 
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